跳转至内容
Merck
CN

L050050

Cap B1

configured for (ÄKTA® and OligoPilot®)

别名:

Cap B

登录并加购,请在购物车里查看协议价、货期和发货地。

选择规格

变更视图

关于此项目

NACRES:
NA.21
UNSPSC Code:
12352200
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


type

for DNA synthesis

Quality Segment

product line

Proligo Reagents

form

liquid

storage condition

dry at room temperature

suitability

conforms to structure (GC, Formulation)

compatibility

configured for (ÄKTA® and OligoPilot®)

General description

Cap B1 solution, containing acetonitrile (ACN) and acetic anhydride, is mixed in situ with Cap A and Cap B2 solution during the capping (acetylation) reaction. Pyridine is applied as a mild base while NMI provides a powerful acylation catalyst.

Preparation Note

乙腈/乙酸酐·6/4 (v/v)

Legal Information

OligoPilot is a registered trademark of Cytiva
ÄKTA is a registered trademark of Cytiva


signalword

Danger

Hazard Classifications

Acute Tox. 2 Inhalation - Acute Tox. 4 Oral - Eye Dam. 1 - Flam. Liq. 2 - Skin Corr. 1B - STOT SE 3

target_organs

Respiratory system

存储类别

3 - Flammable liquids

flash_point_f

35.6 °F - closed cup

flash_point_c

2.0 °C - closed cup



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库